|
|
||||||||
The FASEB Journal, Vol 11, 1077-1089, Copyright © 1997 by The Federation of American Societies for Experimental Biology
REVIEWS |
W Droge and E Holm
Division of Immunochemistry, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
The combination of abnormally low plasma cystine and glutamine levels, low natural killer (NK) cell activity, skeletal muscle wasting or muscle fatigue, and increased rates of urea production defines a complex of abnormalities that is tentatively called "low CG syndrome." These symptoms are found in patients with HIV infection, cancer, major injuries, sepsis, Crohn's disease, ulcerative colitis, chronic fatigue syndrome, and to some extent in overtrained athletes. The coincidence of these symptoms in diseases of different etiological origin suggests a causal relationship. The low NK cell activity in most cases is not life-threatening, but may be disastrous in HIV infection because it may compromise the initially stable balance between the immune system and virus, and trigger disease progression. This hypothesis is supported by the coincidence observed between the decrease of CD4+ T cells and a decrease in the plasma cystine level. In addition, recent studies revealed important clues about the role of cysteine and glutathione in the development of skeletal muscle wasting. Evidence suggests that 1) the cystine level is regulated primarily by the normal postabsorptive skeletal muscle protein catabolism, 2) the cystine level itself is a physiological regulator of nitrogen balance and body cell mass, 3) the cyst(e)ine-mediated regulatory circuit is compromised in various catabolic conditions, including old age, and 4) cysteine supplementation may be a useful therapy if combined with disease- specific treatments such as antiviral therapy in HIV infection.
This article has been cited by other articles:
![]() |
W.S. Waring, A.F.L. Stephen, O.D.G. Robinson, M.A. Dow, and J.M. Pettie Serum urea concentration and the risk of hepatotoxicity after paracetamol overdose QJM, May 1, 2008; 101(5): 359 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Nkabyo, L. H. Gu, D. P. Jones, and T. R. Ziegler Thiol/Disulfide Redox Status Is Oxidized in Plasma and Small Intestinal and Colonic Mucosa of Rats with Inadequate Sulfur Amino Acid Intake J. Nutr., May 1, 2006; 136(5): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Melendez, R. Blanco, W. Delgado, R. Garcia, J. Santana, H. Garcia, O. Rosario, and J. F. Rodriguez Lack of Evidence for In Vivo Transformation of Zidovudine Triphosphate to Stavudine Triphosphate in Human Immunodeficiency Virus-Infected Patients Antimicrob. Agents Chemother., March 1, 2006; 50(3): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Miller, W. H. Watson, W. G. Kirlin, T. R. Ziegler, and D. P. Jones Oxidation of the Glutathione/Glutathione Disulfide Redox State Is Induced by Cysteine Deficiency in Human Colon Carcinoma HT29 Cells J. Nutr., August 1, 2002; 132(8): 2303 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Droge Free Radicals in the Physiological Control of Cell Function Physiol Rev, January 1, 2002; 82(1): 47 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Young and A. M. Ajami Glutamine: The Emperor or His Clothes? J. Nutr., September 1, 2001; 131(9): 2449S - 2459. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Lands, V. L. Grey, and A. A. Smountas Effect of supplementation with a cysteine donor on muscular performance J Appl Physiol, October 1, 1999; 87(4): 1381 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Lands, V. Grey, A. A. Smountas, V. G. Kramer, and D. McKenna Lymphocyte Glutathione Levels in Children With Cystic Fibrosis Chest, July 1, 1999; 116(1): 201 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sato, M. Tamba, T. Ishii, and S. Bannai Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins J. Biol. Chem., April 23, 1999; 274(17): 11455 - 11458. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hack, R. Breitkreutz, R. Kinscherf, H. Rohrer, P. Bartsch, F. Taut, A. Benner, and W. Droge The Redox State as a Correlate of Senescence and Wasting and as a Target for Therapeutic Intervention Blood, July 1, 1998; 92(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |